Russia plans to significantly expand the geography of the export of its drugs this year, paying attention both to emerging nations and developed countries, reports The Pharma Letter’s local correspondent.
At present, Russia supplies about 45,000 tons of drugs annually to more than 160 countries. According to the Russian Ministry of Industry and Trade, in 2024 exports amounted to 180 billion roubles ($18 billion) and, as part of state plans, this figure should grow significantly this year.
Rustem Muratov, general director of Binnopharm Group, one of Russia’s leading drugmakers said in an interview with the Russian Rossiyskay Gazeta business paper, at present there is a high demand for Russian generics in other countries. Also, there is the ever-growing demand for Russian vaccines, particular those against flu, measles, polio and other infections. Finally, Russia also exports a wide range of cardiology drugs.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze